Inhalable Hsa‐miR‐30a‐3p Liposomes Attenuate Pulmonary Fibrosis

Inhalable Hsa‐miR‐30a‐3p Liposomes Attenuate Pulmonary Fibrosis

Abstract Idiopathic pulmonary fibrosis (IPF) remains an incurable form of interstitial lung disease with sub‐optimal treatments that merely address adverse symptoms or slow fibrotic progression. Here, inhalable hsa‐miR‐30a‐3p‐loaded liposomes (miR‐30a) for the treatment of bleomycin‐induced pulmonar...

Full description

Saved in:
Bibliographic Details
Main Authors: Shuo Liu, Kristen D. Popowski, Christina M. Eckhardt, Weihang Zhang, Junlang Li, Yujia Jing, Dylan Silkstone, Elizabeth Belcher, Megan Cislo, Shiqi Hu, Halle Lutz, Asma Ghodsi, Mengrui Liu, Phuong‐Uyen C. Dinh, Ke Cheng
Format: Article
Language:English
Published: Wiley 2025-05-01
Series:Advanced Science
Subjects:
CNPY2
idiopathic pulmonary fibrosis
inhalation
miR‐30a‐3p
Online Access:https://doi.org/10.1002/advs.202405434
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/advs.202405434

Similar Items